Active Ingredient(s):Pemetrexed FDA Approved: * February 4, 2004 Pharm Company: *LILLY Category:Cancer
Pemetrexed, sold under the brand name Alimta among others, is a chemotherapy medication for the treatment of pleural mesothelioma and non-small cell lung cancer (NSCLC).
1 Medical use
2 Side effects
3 Mechanism of action
5 Society and culture
5.1 Trade names
8 External links
In February 2004, the U.S. Food and Drug Administration (FDA) approved pemetrexed for treatment of malignant...
* May have multiple approval dates, manufacturers, or labelers. 3 Discussions
Alimta 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution